# DESCRIPTION

- claim priority from provisional application

## INTRODUCTION

- introduce SVCV and its impact on carp populations
- describe SVCV outbreaks in North America
- discuss limitations of current SVCV control methods
- motivate DNA vaccines as an alternative
- summarize previous SVCV DNA vaccine research

## SUMMARY OF THE INVENTION

- describe novel SVCV DNA vaccine construct
- summarize vaccine trial results

## DETAILED DESCRIPTION

- define key terms in recombinant DNA and immunology
- explain epitope and antigenic determinant
- define solid phase, biological sample, and biological fluid
- explain immunologically reactive, immune complex, and purified proteins
- define recombinantly expressed, lower eukaryote, prokaryotes, and higher eukaryote
- explain polypeptide, recombinant polynucleotide, and control sequences
- introduce DNA vaccine and methods for protecting against SVCV
- define isolated DNA
- describe DNA delivery methods
- outline vector and host cell systems
- explain expression control sequences
- detail vaccine composition and administration
- describe immunoassay methods
- introduce SVCV vaccine, proteins, peptides, or antigens
- describe kit for immunoassays
- outline method for in vitro monitoring SVCV infection
- describe kit for in vitro diagnosis of G protein antigen
- outline method for in vitro diagnosis of G protein antigen
- describe monoclonal antibodies as therapeutic and prophylactic agents
- outline method for active immunization
- describe materials and methods used in examples
- outline susceptible challenges of goldfish and koi
- describe cold stress challenges in koi
- outline vaccine construction and vaccination

### Susceptibility Testing of Goldfish and Koi

- compare susceptibility of goldfish and koi to SVCVnc

### Example 2

- evaluate cold stress challenge in koi

### Example 3

- describe vaccine trials
- summarize mortality results
- discuss vaccine efficacy

